Abstract
Interactions between the benzodiazepines (BZs) chlordiazepoxide (CDP) and midazolam (MDZ), the BZ antagonist R0 15-1788, the inverse BZ receptor agonists CGS 8216 and FG 7142, γ-aminobutyrate (GABA), serotonin (5-HT), the 5-HT2 antagonist methysergide and the putative 5-HT agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were investigated using peripheral and intra-amygdaloid treatments. A multiple schedule consisting of rewarded, nonrewarded (Time out: TO) and conflict periods was used to compare in parallel effects on successive discrimination between rewarded and nonrewarded periods and punished responding. The three components were presented in both a fixed order (Experiment 1) and a random order (Experiments 2 and 3).
Intra-amygdaloid treatments with GABA and the BZs selectively increased rates of punished responding. CDP given systemically, on the other hand, increased both TO and conflict rates, suggesting an additional impairment of discrimination, which was more marked in the random than the fixed order condition. R0 15-1788, CGS 8216 and FG 7142 given by both routes counteracted the anti-conflict effects of CDP given centrally or systemically. However increases in TO rates induced by IP CDP were antagonized only by IP treatments with these compounds. The two inverse agonists, but not R0 15-1788, also counteracted increases in punished responding which were found after intra-amygdaloid GABA infusions. In Experiments 2 and 3 where baseline rates of pressing in Conflict periods were sufficiently high to detect decreases, CGS 8216 and FG 7142 reduced responding below control level, suggesting a specific anxiogenic activity. Evidence for effects of R0 15-1788 by itself was inconclusive. 5-HT injected into the amygdala also reduced punished responding below control level, whereas methysergide increased it with both central and peripheral treatment. Effects of 8-OH-DPAT varied according to route of administration. With IP treatment Conflict rates were increased, but after amygdaloid infusion both TO and Conflict rates were marginally reduced below control level, with a more consistent depression of punished responding.
These results provide evidence that effects of BZs on punished responding are mediated by a GABAergic system which includes the lateral/basolateral amygdala, but which does not participate in BZ-induced disruption of discrimination. They also indicate that the antagonistic effects of CGS 8216 and FG 7142 involve a decrease in GABA transmission, and that these compounds may also be anxiogenic. Finally, the results suggest that 5-HT utilizes the same system for regulating resistance to punishment, but plays no significant part in reward-nonreward successive discrimination, which is impaired after systemic BZs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonetti EP, Pieri L, Cumin R, Schnaffner R, Gamzu ER, Muller RKM, Haefely W (1982) Benzodiazepine antagonist R0 15–1788: neurological and behavioural effects. Psychopharmacology 78:8–18
Bovier P, Broekkamp CLE, Lloyd KG (1982) Enhancing GA-BAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region. Brain Res 248:313–320
Brandao ML, De Aguiar JC, Graeff FG (1982) GABA mediation of the anti-aversive action of minor tranquillizers. Pharmacol Biochem Behav 16:397–402
Buckland C, Mellanby J, Gray JA (1986) The effects of compounds related to γ-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: extinction and successive discrimination. Psychopharmacology 88:285–295
Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86:197–204
Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S (1984) Anti-conflict effect of the putative serotonin agonist 8-hyddroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Eur J Pharmacol 108:365–368
Feldon J, Lerner T, Levin D, Myslobodsky M (1983) A behavioural examination of convulsant benzodiazepines and GABA antagonist, Ro 5–3663, and benzodiazepine-receptor antagonist R0 15–1788. Pharmacol Biochem Behav 19:39–41
File SE, Pellow S (1986) Intrinsic actions of the benzodiazepine receptor antagonist R0 15–1788. Psychopharmacology 88:1–11
File SE, Lister RG, Nutt DJ (1982) The anxiogenic action of benzodiazepine antagonists. Neuropharmacology 21:1033–1037
Goslan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand 3H-PAT. Nature 305:140–142
Graeff FG, Rawlins JNP (1980) Dorsal periaqueductal gray, punishment, septal lesions and the mode of action of minor tranquillizers. Pharmacol Biochem Behav 12:41–45
Gray JA (1982) The neuropsychology of anxiety. OUP, Oxford
Green S, Hodges H (1986) Differential effects of dorsal raphe lesions and intraraphe GABA and benzodiazepines on conflict behaviour in rats. Behav Neural Biol 46:13–29
Hodges H, Green S (1984) Evidence for the involvement of brain GABA and serotonin systems in the anti-conflict effects of chlordiazepoxide in rats. Behav Neural Biol 40:127–154
Hodges H, Baum S, Taylor P, Green S (1986) Behavioural and pharmacological dissociation of chlordiazepoxide effects on discrimination and punished responding. Psychopharmacology 59:155–161
Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schnaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516
Iversen SD (1983) Where in the brain do benzodiazepines act? In: Trimble MR (ed) Benzodiazepines divided. Wiley, Chichester
Jensen LH, Petersen EN, Braestrup C, Honore T, Kehr W, Stephens DN, Schneider H, Seidelman D, Schmiechen R (1984) Evaluation of the β carboline ZK93426 as a benzodiazepine receptor antagonist. Psychopharmacology 83:249–256
Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Brooks/Cole, Belmont, CA
Middlemiss DN (1984) 8-hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the (3H)5-HT recognition site. Naunyn Schmiedeberg's Arch Pharmacol 327:18–22
Pellegrino LJ, Cushman AJ (1967) A stereotaxic atlas of the rat brain. Meredith
Pellow S, File SE (1984) Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations. Psychopharmacology 83:304–315
Petersen EN, Jensen LH (1984) Proconflict effects of benzodiazepine receptor inverse agonists and other inhibitors of GABA function. Eur J Pharmacol 103:91–97
Petersen EN, Scheel-Krüger J (1982) The GABAergic anticonflict effects of intra amygdaloid benzodiazepines demonstrated by a new waterlick conflict paradigm. In: Spiegelstein MY, Levy A (eds) Behavioral models and analyses of drug action. Proceedings of the 27th OHOLO Conference. Zichron Ya'acov, Israel. Elsevier, Amsterdam
Petersen EN, Scheel-Krüger J (1984) Anticonflict effects of 5-HT antagonists by intraamygdaloid injection. 14th CINP Congress, Florence, p 339
Petersen EN, Honore T, Braestrup C (1983) Differential pharmacological effects of benzodiazepine receptor inverse agonists. In: Biggio C, Costa E (eds) Benzodiazepine receptor site ligands: biochemistry and pharmacology. Raven, New York
Polc P, Bonetti EP, Schnaffner R, Haefely W (1982) A three-state model of the benzodiazepine-receptor explains the interactions between the benzodiazepine antagonist R0 15–1788, benzodiazepine tranquillizers, β carbolines and phenobarbitone. Naunyn Schmiedeberg's Arch Pharmacol 321:260–264
Quintero S, Henney S, Lawson P, Mellanby J, Gray JA (1985) The effects of compounds related to γ-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: punished bar pressing. Psychopharmacology 85:244–251
Scheel-Krüger J, Petersen EN (1982) Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala. Eur J Pharmacol 83:115–116
Schutz MTB, de Agiuar JC, Graeff FG (1985) Anti-aversive role of serotonin in the dorsal periacqueductal gray matter. Psychopharmacology 85:340–345
Sepinwall J, Cook L (1978) Behavioural pharmacology of anti-anxiety drugs. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol. 13. Plenum, New York
Stein L, Wise CD, Berger BD (1973) Antianxiety action of benzodiazepines: decreases in activity of serotonin neurons in punishment systems. In: Costa E, Garratini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York
Thiebot MH, Jobert A, Soubrie P (1980) Chlordiazepoxide and GABA injected into raphe dorsalis release the conditioned behavioural suppression induced in rats by a conflict procedure without a nociceptive component. Neuropharmacology 19:633–641
Thiebot MH, Hamon M, Soubrie P (1982) Attenuation of induced anxiety in rats by chlordiazepoxide. Role of raphe dorsalis benzodiazepine binding sites and serotonergic neurons. Neuroscience 7:2287–2294
Thiebot MH, Soubrie P, Hamon MM, Simon P (1984) Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat. Psychopharmacology 82:355–359
Thomas SR, Iversen SD (1985) Correlation of 3H-diazepam binding density with anxiolytic locus in the amygdaloid complex of the rat. Brain Res 342:85–90
Tye NC, Iversen SD, Green AR (1979) Effects of benzodiazepines and serotonergic manipulations on punished responding. Neuropharmacology 18:689–695
Author information
Authors and Affiliations
Additional information
This work was supported by the award of the MRC project Grant No. 8313090N to SG
Rights and permissions
About this article
Cite this article
Hodges, H., Green, S. & Glenn, B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology 92, 491–504 (1987). https://doi.org/10.1007/BF00176484
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00176484